Is FluoroPharma Medical, Inc. (FPMI) a Buy, Sell, or Hold?
OTC : FPMI
FluoroPharma Medical, Inc.
$0.0002 USD
$0 (0.0%)
- Volume
- 1.19M
- Average Volume
- 351
- Market Capitalization
- $6.85K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.00
Company Overview
OTC
Edward L. Lyons Jr.
Biotechnology
Healthcare
FPMI
4
US
USD
Liquidity Metrics
-0.57
0.00
0.00
0.00
0.00
Sales & Valuation
-$
0.00
0.00
-0.01
-0.03
Profitability
-$0.0611
-$2.05M
0.00%
0.00%
22.73%
-612.34%
P/E Metrics
0.00
0.00
0.00
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-206.32
1/9
-$10.47M
$334.76K
$10.51M
-$2.2M
Key Metrics (TTM)
$5.81M
0.00
-7.80
0.00
22.73%
29.52%
-30543.70%
-12863.60%
-11752 days
Company Executives
| Name | Title |
|---|---|
| Edward L. Lyons Jr. | Vice President of Development |
Poll Results
No votes yet today — be the first to share your view!
About FluoroPharma Medical, Inc. (OTC:FPMI) Stock
FluoroPharma Medical, Inc. (FPMI) is a biopharmaceutical firm dedicated to the discovery, development, and commercialization of advanced molecular imaging agents. Initially, its efforts are concentrated on cardiovascular applications within the United States market. The company's pipeline features two notable product candidates: BFPET: An imaging agent designed for stress-testing patients with suspected or confirmed coronary artery disease (CAD), which has successfully completed its Phase I clinical trial. CardioPET: Another molecular imaging agent, currently undergoing a Phase IIa clinical trial. This compound aims to evaluate myocardial blood flow and metabolism in individuals afflicted with CAD. FluoroPharma Medical has established key collaborations, including licensing agreements with ... Massachusetts General Hospital and Sinotau USA. Furthermore, the company holds clinical research agreements with Pharmaceutical Product Development, LLC, and Cardiovascular Imaging Technologies. Established in 2003, FluoroPharma Medical, Inc. is headquartered in Montclair, New Jersey.
Frequently Asked Questions
-
What is the current FluoroPharma Medical, Inc. (FPMI) stock price?
-
FluoroPharma Medical, Inc.(OTC:FPMI) stock price is $0.0002 in the last trading session. During the trading session, FPMI stock reached the peak price of $0.0002 while $0.0001 was the lowest point it dropped to. The percentage change in FPMI stock occurred in the recent session was 0.0% while the dollar amount for the price change in FPMI stock was $0.
-
FPMI's industry and sector of operation?
-
The OTC listed FPMI is part of Biotechnology industry that operates in the broader Healthcare sector.
-
Who are the executives of FPMI?
-
Edward L. Lyons Jr. | Vice President of Development
|
|
|
| -
How many employees does FPMI have?
-
Number of FPMI employees currently stands at 4. FPMI operates from 8 Hillside Avenue, Montclair, NJ 07042, US.
-
Link for FPMI official website?
-
Official Website of FPMI is: https://www.fluoropharma.com
-
How do I contact FPMI?
-
FPMI could be contacted at phone #973-744-1565 and can also be accessed through its website. FPMI operates from 8 Hillside Avenue, Montclair, NJ 07042, US.
-
How many shares of FPMI are traded daily?
-
The average number of FPMI shares traded daily for last 3 months was 351.
-
What is the market cap of FPMI currently?
-
The market value of FPMI currently stands at $6.85K with its latest stock price at $0.0002